Mayoux E - Search Results

1

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.

Rieg T, Masuda T, Gerasimova M, Mayoux E, Platt K, Powell DR, Thomson SC, Koepsell H, Vallon V. Rieg T, et al. Among authors: mayoux e. Am J Physiol Renal Physiol. 2014 Jan;306(2):F188-93. doi: 10.1152/ajprenal.00518.2013. Epub 2013 Nov 13. Am J Physiol Renal Physiol. 2014. PMID: 24226519 Free PMC article.

2

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.

Vallon V, Gerasimova M, Rose MA, Masuda T, Satriano J, Mayoux E, Koepsell H, Thomson SC, Rieg T. Vallon V, et al. Among authors: mayoux e. Am J Physiol Renal Physiol. 2014 Jan;306(2):F194-204. doi: 10.1152/ajprenal.00520.2013. Epub 2013 Nov 13. Am J Physiol Renal Physiol. 2014. PMID: 24226524 Free PMC article.

3

Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin.

Fu Y, Breljak D, Onishi A, Batz F, Patel R, Huang W, Song P, Freeman B, Mayoux E, Koepsell H, Anzai N, Nigam SK, Sabolic I, Vallon V. Fu Y, et al. Among authors: mayoux e. Am J Physiol Renal Physiol. 2018 Aug 1;315(2):F386-F394. doi: 10.1152/ajprenal.00503.2017. Epub 2018 Feb 7. Am J Physiol Renal Physiol. 2018. PMID: 29412698 Free PMC article.

4

A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans.

Michel MC, Mayoux E, Vallon V. Michel MC, et al. Among authors: mayoux e. Naunyn Schmiedebergs Arch Pharmacol. 2015 Aug;388(8):801-16. doi: 10.1007/s00210-015-1134-1. Epub 2015 Jun 26. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26108304 Free PMC article. Review.

5

The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.

Gembardt F, Bartaun C, Jarzebska N, Mayoux E, Todorov VT, Hohenstein B, Hugo C. Gembardt F, et al. Among authors: mayoux e. Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F317-25. doi: 10.1152/ajprenal.00145.2014. Epub 2014 Jun 18. Am J Physiol Renal Physiol. 2014. PMID: 24944269 Free article.

6

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.

Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, DeMarco VG. Aroor AR, et al. Among authors: mayoux e. Cardiovasc Diabetol. 2018 Jul 30;17(1):108. doi: 10.1186/s12933-018-0750-8. Cardiovasc Diabetol. 2018. PMID: 30060748 Free PMC article.

7

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

Habibi J, Aroor AR, Sowers JR, Jia G, Hayden MR, Garro M, Barron B, Mayoux E, Rector RS, Whaley-Connell A, DeMarco VG. Habibi J, et al. Among authors: mayoux e. Cardiovasc Diabetol. 2017 Jan 13;16(1):9. doi: 10.1186/s12933-016-0489-z. Cardiovasc Diabetol. 2017. PMID: 28086951 Free PMC article.

8

The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.

Cheng ST, Chen L, Li SY, Mayoux E, Leung PS. Cheng ST, et al. Among authors: mayoux e. PLoS One. 2016 Jan 25;11(1):e0147391. doi: 10.1371/journal.pone.0147391. eCollection 2016. PLoS One. 2016. PMID: 26807719 Free PMC article.

9

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.

Xu L, Nagata N, Nagashimada M, Zhuge F, Ni Y, Chen G, Mayoux E, Kaneko S, Ota T. Xu L, et al. Among authors: mayoux e. EBioMedicine. 2017 Jun;20:137-149. doi: 10.1016/j.ebiom.2017.05.028. Epub 2017 May 26. EBioMedicine. 2017. PMID: 28579299 Free PMC article.

10

Fingerprints of hSGLT5 sugar and cation selectivity.

Ghezzi C, Gorraitz E, Hirayama BA, Loo DD, Grempler R, Mayoux E, Wright EM. Ghezzi C, et al. Among authors: mayoux e. Am J Physiol Cell Physiol. 2014 May 1;306(9):C864-70. doi: 10.1152/ajpcell.00027.2014. Epub 2014 Feb 26. Am J Physiol Cell Physiol. 2014. PMID: 24573086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page